Source Match Health News
BTG builds interventional medicine platform with deals
Iran pushes ahead with nuclear plant that worries West
By Fredrik Dahl VIENNA (Reuters) - Iran is pressing ahead with
the construction of a research reactor that Western experts say
could eventually produce plutonium for a nuclear weapon if Tehran
decides to make one, a U.N. report showed on Wednesday. In another
development likely to worry the United States and its allies, the
U.N. International Atomic Energy Agency said Iran had added to its
capacity to refine uranium, which can also provide the fissile core
of a bomb if enriched to a high level. The IAEA also said Iran had
asphalted a part of a military site, Parchin, that the U.N. ...
Nissan to recall 841,000 vehicles due to steering wheel glitch
TOKYO (Reuters) - Nissan Motor Co Ltd will recall about 841,000
vehicles worldwide including the Micra compact car, also known as
the March, as a result of a steering wheel glitch, Japan's No.2
automaker said on Thursday. Nissan is recalling certain models of
the Micra compact car produced in Britain and Japan between 2002
and 2006, as well as the Cube, produced in Japan around the same
period. It is pulling back vehicles in Japan, Europe, Asia,
Oceania, Africa, Latin America and the Middle East. ...
Pfizer takes its shot at a vaccine for evasive superbug
By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a
microbiologist with at least two breakthrough vaccines to her name:
she brought the cervical cancer vaccine Gardasil to market for
Merck and helped develop the $4 billion a year pneumonia and
meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine
success could come by taming the superbug MRSA, a drug-resistant
bacterium that she has seen ravage a healthy man up close and
personally. Methicillin-resistant Staphylococcus aureus infects an
estimated 53 million people globally and costs more than $20
billion a year to treat. ...
Building materials blamed in Bangladesh disaster
DHAKA, Bangladesh (AP) — A government investigation found that
"extremely" poor quality construction materials and a series of
violations caused the collapse of a garment factory building in
Bangladesh that has been called the worst garment-industry disaster
in history, the committee head said Thursday.
Teen birth rates decline in most US states
Nebraska attorney general wants abortion clinic nurse's license revoked
Man linked to Boston bombing suspect killed by FBI in Florida
By Barbara Liston and Mark Hosenball ORLANDO, Fla./WASHINGTON
(Reuters) - A Chechen immigrant who was being questioned about his
possible links to one of the Boston Marathon bombing suspects was
shot and killed by a federal agent in Florida on Wednesday after he
suddenly turned violent, the FBI said. A friend of the dead man
identified him to Reuters as 27-year-old Ibragim Todashev, who had
previously lived in Boston and knew Tamerlan Tsarnaev, the older of
the two brothers suspected of planting two bombs at the marathon on
April 15, killing three people and injuring 264. ...
4 Americans killed since 2009 in US drone strikes
WASHINGTON (AP) — The Obama administration acknowledged for the
first time Wednesday that four American citizens have been killed
in drone strikes in Pakistan and Yemen since 2009. The disclosure
to Congress comes on the eve of a major national security speech by
President Barack Obama in which he plans to pledge more
transparency to Congress in his counterterrorism policy.
Merck's insomnia drug moves a step closer to U.S. approval
By Toni Clarke WASHINGTON (Reuters) - Merck & Co's
experimental insomnia drug moved a step closer to U.S. approval on
Wednesday after a panel of medical experts said it is effective and
safe at lower doses. The advisory panel was convened to help the
U.S. Food and Drug Administration decide whether to approve the
drug, suvorexant, which would be the first in a new class of
sedatives that block chemicals in the brain called orexins that
help keep people awake. The drugs are designed to help people fall
asleep and stay asleep. ...
Merck's insomnia drug moves a step closer to U.S. approval
By Toni Clarke WASHINGTON (Reuters) - Merck & Co's
experimental insomnia drug moved a step closer to U.S. approval on
Wednesday after a panel of medical experts said it is effective and
safe at lower doses. The advisory panel was convened to help the
U.S. Food and Drug Administration decide whether to approve the
drug, suvorexant, which would be the first in a new class of
sedatives that block chemicals in the brain called orexins that
help keep people awake. The drugs are designed to help people fall
asleep and stay asleep. ...
Fluoride Loosens Bacterial Enamel Grip
Vote on pot shops could end lingering LA issue
Senate committee advances drug compounding bill
FDA panel says Merck's sleep drug safe, effective at lower dose
By Toni Clarke WASHINGTON (Reuters) - Merck & Co's
experimental insomnia drug was safe and effective at the lower of
two doses studied, a panel of medical experts said on Wednesday,
increasing the chance it will be approved by the U.S. Food and Drug
Administration. The advisory panel was convened to help the FDA
decide whether to approve the drug, suvorexant, which would be the
first in a new class of sedatives designed to help people fall
asleep and stay asleep. ...
Pocket-dialing 911 leads to Fla. murder charge
Health officials probe deadly respiratory illness in Alabama